Macleods Pharmaceuticals Limited Discontinued
FDA Approved Drugs
Macleods Pharmaceuticals Limited Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 56
- Latest Approval Date May 12, 2025
- Data Source FDA
- First Approval Date Feb 16, 2012
Company Overview
Company
Macleods Pharmaceuticals Limited Discontinued
Country
India
Website
Social Profiles
Company Snapshot
Macleods Pharmaceuticals Limited Discontinued
Atlanta Arcade, Marol Church Road, Andheri (East), Mumbai - 400059
India
www.macleodspharma.com/ exports@macleodspharma.com View on MapFDA Approved Drug Records ( 56 records )
Drug Name
ABACAVIR SULFATE AND LAMIVUDINE
Product Number
1
Dosage Form
-
Strength
EQ 600MG BASE;300MG
Approval Date
2024-12-19
Active Ingredient
ABACAVIR SULFATE; LAMIVUDINE
Application Number
212663
Product Number
1
Dosage Form
-
Strength
EQ 600MG BASE;300MG
Approval Date
2024-12-19
Regulatory Status
Discontinued
Drug Name
APIXABAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-02-27
Active Ingredient
APIXABAN
Application Number
210067
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2025-02-27
Regulatory Status
Discontinued
Drug Name
APIXABAN
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2025-02-27
Active Ingredient
APIXABAN
Application Number
210067
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2025-02-27
Regulatory Status
Discontinued
Drug Name
APREMILAST
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-11-25
Active Ingredient
APREMILAST
Application Number
211788
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-11-25
Regulatory Status
Discontinued
Drug Name
APREMILAST
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2024-11-25
Active Ingredient
APREMILAST
Application Number
211788
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2024-11-25
Regulatory Status
Discontinued
Drug Name
APREMILAST
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2024-11-25
Active Ingredient
APREMILAST
Application Number
211788
Product Number
3
Dosage Form
-
Strength
30MG
Approval Date
2024-11-25
Regulatory Status
Discontinued
Drug Name
CHOLESTYRAMINE LIGHT
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
2024-10-31
Active Ingredient
CHOLESTYRAMINE
Application Number
209109
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
2024-10-31
Regulatory Status
Discontinued
Drug Name
CHOLESTYRAMINE LIGHT
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
2024-10-31
Active Ingredient
CHOLESTYRAMINE
Application Number
209109
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
2024-10-31
Regulatory Status
Discontinued
Drug Name
CLOBETASOL PROPIONATE
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2024-12-02
Active Ingredient
CLOBETASOL PROPIONATE
Application Number
214345
Product Number
1
Dosage Form
-
Strength
0.05%
Approval Date
2024-12-02
Regulatory Status
Discontinued
Drug Name
COLESEVELAM HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
625MG
Approval Date
2025-04-18
Active Ingredient
COLESEVELAM HYDROCHLORIDE
Application Number
204893
Product Number
1
Dosage Form
-
Strength
625MG
Approval Date
2025-04-18
Regulatory Status
Discontinued
Drug Name
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
400MG;300MG;300MG
Approval Date
2019-03-15
Active Ingredient
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
210649
Product Number
1
Dosage Form
-
Strength
400MG;300MG;300MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
ESOMEPRAZOLE MAGNESIUM
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-10-23
Active Ingredient
ESOMEPRAZOLE MAGNESIUM
Application Number
208511
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-10-23
Regulatory Status
Discontinued
Drug Name
ESOMEPRAZOLE MAGNESIUM
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-10-23
Active Ingredient
ESOMEPRAZOLE MAGNESIUM
Application Number
208511
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-10-23
Regulatory Status
Discontinued
Drug Name
EZETIMIBE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-04-29
Active Ingredient
EZETIMIBE
Application Number
211159
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-04-29
Regulatory Status
Discontinued
Drug Name
FENOFIBRIC ACID
Product Number
1
Dosage Form
-
Strength
EQ 45MG FENOFIBRIC ACID
Approval Date
2024-02-08
Active Ingredient
CHOLINE FENOFIBRATE
Application Number
207796
Product Number
1
Dosage Form
-
Strength
EQ 45MG FENOFIBRIC ACID
Approval Date
2024-02-08
Regulatory Status
Discontinued
Drug Name
FENOFIBRIC ACID
Product Number
2
Dosage Form
-
Strength
EQ 135MG FENOFIBRIC ACID
Approval Date
2024-02-08
Active Ingredient
CHOLINE FENOFIBRATE
Application Number
207796
Product Number
2
Dosage Form
-
Strength
EQ 135MG FENOFIBRIC ACID
Approval Date
2024-02-08
Regulatory Status
Discontinued
Drug Name
HYDRALAZINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-08-21
Active Ingredient
HYDRALAZINE HYDROCHLORIDE
Application Number
211010
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2024-08-21
Regulatory Status
Discontinued
Drug Name
HYDRALAZINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2024-08-21
Active Ingredient
HYDRALAZINE HYDROCHLORIDE
Application Number
211010
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2024-08-21
Regulatory Status
Discontinued
Drug Name
HYDRALAZINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2024-08-21
Active Ingredient
HYDRALAZINE HYDROCHLORIDE
Application Number
211010
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2024-08-21
Regulatory Status
Discontinued
Drug Name
HYDRALAZINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2024-08-21
Active Ingredient
HYDRALAZINE HYDROCHLORIDE
Application Number
211010
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2024-08-21
Regulatory Status
Discontinued
Drug Name
LANSOPRAZOLE
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2024-11-04
Active Ingredient
LANSOPRAZOLE
Application Number
208671
Product Number
1
Dosage Form
-
Strength
15MG
Approval Date
2024-11-04
Regulatory Status
Discontinued
Drug Name
LANSOPRAZOLE
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2024-11-04
Active Ingredient
LANSOPRAZOLE
Application Number
208671
Product Number
2
Dosage Form
-
Strength
30MG
Approval Date
2024-11-04
Regulatory Status
Discontinued
Drug Name
LINEZOLID
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2024-10-10
Active Ingredient
LINEZOLID
Application Number
210378
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2024-10-10
Regulatory Status
Discontinued
Drug Name
METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1GM
Approval Date
2024-03-13
Active Ingredient
METFORMIN HYDROCHLORIDE
Application Number
211163
Product Number
1
Dosage Form
-
Strength
1GM
Approval Date
2024-03-13
Regulatory Status
Discontinued
Drug Name
PANTOPRAZOLE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-02-16
Active Ingredient
PANTOPRAZOLE SODIUM
Application Number
200821
Product Number
1
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-02-16
Regulatory Status
Discontinued
Drug Name
PANTOPRAZOLE SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2012-02-16
Active Ingredient
PANTOPRAZOLE SODIUM
Application Number
200821
Product Number
2
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2012-02-16
Regulatory Status
Discontinued
Drug Name
PRAMIPEXOLE DIHYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
2012-09-20
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE
Application Number
202164
Product Number
1
Dosage Form
-
Strength
0.125MG
Approval Date
2012-09-20
Regulatory Status
Discontinued
Drug Name
PRAMIPEXOLE DIHYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
2012-09-20
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE
Application Number
202164
Product Number
2
Dosage Form
-
Strength
0.25MG
Approval Date
2012-09-20
Regulatory Status
Discontinued
Drug Name
PRAMIPEXOLE DIHYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
0.5MG
Approval Date
2012-09-20
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE
Application Number
202164
Product Number
3
Dosage Form
-
Strength
0.5MG
Approval Date
2012-09-20
Regulatory Status
Discontinued
Drug Name
PRAMIPEXOLE DIHYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
2012-09-20
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE
Application Number
202164
Product Number
4
Dosage Form
-
Strength
1MG
Approval Date
2012-09-20
Regulatory Status
Discontinued
Drug Name
PRAMIPEXOLE DIHYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
1.5MG
Approval Date
2012-09-20
Active Ingredient
PRAMIPEXOLE DIHYDROCHLORIDE
Application Number
202164
Product Number
5
Dosage Form
-
Strength
1.5MG
Approval Date
2012-09-20
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
3
Dosage Form
-
Strength
75MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
5
Dosage Form
-
Strength
150MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
5
Dosage Form
-
Strength
150MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
6
Dosage Form
-
Strength
200MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
6
Dosage Form
-
Strength
200MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
7
Dosage Form
-
Strength
225MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
7
Dosage Form
-
Strength
225MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
8
Dosage Form
-
Strength
300MG
Approval Date
2024-11-12
Active Ingredient
PREGABALIN
Application Number
205924
Product Number
8
Dosage Form
-
Strength
300MG
Approval Date
2024-11-12
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2024-11-06
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207296
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2024-11-06
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2024-11-06
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207296
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2024-11-06
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-11-06
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207296
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2024-11-06
Regulatory Status
Discontinued
Drug Name
ROSUVASTATIN CALCIUM
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-11-06
Active Ingredient
ROSUVASTATIN CALCIUM
Application Number
207296
Product Number
4
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-11-06
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;40MG
Approval Date
2015-11-02
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
204169
Product Number
1
Dosage Form
-
Strength
12.5MG;40MG
Approval Date
2015-11-02
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2015-11-02
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
204169
Product Number
2
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2015-11-02
Regulatory Status
Discontinued
Drug Name
TELMISARTAN AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;80MG
Approval Date
2015-11-02
Active Ingredient
HYDROCHLOROTHIAZIDE; TELMISARTAN
Application Number
204169
Product Number
3
Dosage Form
-
Strength
25MG;80MG
Approval Date
2015-11-02
Regulatory Status
Discontinued
Drug Name
TRAMADOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2015-09-25
Active Ingredient
TRAMADOL HYDROCHLORIDE
Application Number
205702
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
2015-09-25
Regulatory Status
Discontinued
Drug Name
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
Product Number
1
Dosage Form
-
Strength
325MG;37.5MG
Approval Date
2017-05-02
Active Ingredient
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
Application Number
206885
Product Number
1
Dosage Form
-
Strength
325MG;37.5MG
Approval Date
2017-05-02
Regulatory Status
Discontinued
Drug Name
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
25MG;37.5MG
Approval Date
2025-01-28
Active Ingredient
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Application Number
214611
Product Number
1
Dosage Form
-
Strength
25MG;37.5MG
Approval Date
2025-01-28
Regulatory Status
Discontinued
Drug Name
ZOLMITRIPTAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2015-09-30
Active Ingredient
ZOLMITRIPTAN
Application Number
203772
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2015-09-30
Regulatory Status
Discontinued
Drug Name
ZOLMITRIPTAN
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-09-30
Active Ingredient
ZOLMITRIPTAN
Application Number
203772
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-09-30
Regulatory Status
Discontinued
Drug Name
ZOLMITRIPTAN
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2015-10-22
Active Ingredient
ZOLMITRIPTAN
Application Number
204336
Product Number
1
Dosage Form
-
Strength
2.5MG
Approval Date
2015-10-22
Regulatory Status
Discontinued
Drug Name
ZOLMITRIPTAN
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-10-22
Active Ingredient
ZOLMITRIPTAN
Application Number
204336
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2015-10-22
Regulatory Status
Discontinued
Drug Name
ZONISAMIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2025-05-12
Active Ingredient
ZONISAMIDE
Application Number
219507
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2025-05-12
Regulatory Status
Discontinued
Drug Name
ZONISAMIDE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-05-12
Active Ingredient
ZONISAMIDE
Application Number
219507
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2025-05-12
Regulatory Status
Discontinued
Drug Name
ZONISAMIDE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2025-05-12
Active Ingredient
ZONISAMIDE
Application Number
219507
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2025-05-12
Regulatory Status
Discontinued
Drug Status Breakdown
56 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABACAVIR SULFATE AND LAMIVUDINE
Application Number
212663
Product Number
1
Active Ingredient
ABACAVIR SULFATE; LAMIVUDINE
Dosage Form
-
Strength
EQ 600MG BASE;300MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.